Search results for “Botulin toxin” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 181 patents, we discovered top 34 key players by total patent application. Allergan, Inc., Biomadison Inc, Daewoong Co., Ltd. are dominant in this area. They take 46.41% of the total patent filing.
Allergan, Inc.
California, United States
Patent: 55
Biomadison Inc
United States
Patent: 17
Daewoong Co., Ltd.
Gyeonggi-do, South Korea
Patent: 12
STARTUP
Eirion Therapeutics, Inc.
Massachusetts, United States
Patent: 11
Ipsen Biopharm Ltd.
WALES, United Kingdom
Patent: 6
Revance Therapeutics, Inc.
California, United States
Patent: 5
Hugel, Inc.
South Korea
Patent: 5
Medytox Inc.
South Korea
Patent: 5
Galderma Holding SA
Vaud, Switzerland
Patent: 5
Jetema Co., Ltd.
South Korea
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 15 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Eirion Therapeutics, Inc.
Massachusetts, United States
Patent: 11
STARTUP
Abbio, Inc.
Washington, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 117 patents applied in the last 5 years. We discover 38 most active companies in this area. The fast-growing Allergan, Inc., Eirion Therapeutics, Inc., Ipsen Biopharm Ltd. take 35.04% of patent filing during this period.
Allergan, Inc.
California, United States
Patent: 24
STARTUP
Eirion Therapeutics, Inc.
Massachusetts, United States
Patent: 11
Ipsen Biopharm Ltd.
WALES, United Kingdom
Patent: 6
Galderma Holding SA
Vaud, Switzerland
Patent: 5
Hugel, Inc.
South Korea
Patent: 5
Daewoong Co., Ltd.
Gyeonggi-do, South Korea
Patent: 4
Jetema Co., Ltd.
South Korea
Patent: 4
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 3
Merck Patent GmbH
Hessen, Germany
Patent: 3
Penland Foundation
United States
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 117 patents in last 5 years, we discover 30 new entrants. Eirion Therapeutics, Inc., Ipsen Biopharm Ltd., Galderma Holding SA are the most active new entrants in this area.
STARTUP
Eirion Therapeutics, Inc.
Massachusetts, United States
Patent: 11
Ipsen Biopharm Ltd.
WALES, United Kingdom
Patent: 6
Galderma Holding SA
Vaud, Switzerland
Patent: 5
Hugel, Inc.
South Korea
Patent: 5
Jetema Co., Ltd.
South Korea
Patent: 4
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 3
Penland Foundation
United States
Patent: 3
Fondation Imagine
France
Patent: 3
Designed Cells Co. Ltd.
South Korea
Patent: 3
Institut National de la Santé et de la Recherche Médicale
France
Patent: 3
Research Institutions
Order by:
Innovation Intensity
With the analysis among 17 patents, we discovered top 6 universities and scientific research institutions by total patent application. Université Toulouse III - Paul Sabatier, Tufts University, University of Nebraska are dominant in this area. They take 52.94% of the total patent filing.
Université Toulouse III - Paul Sabatier
France
Patent: 2
Tufts University
Massachusetts, United States
Patent: 1
University of Nebraska
Nebraska, United States
Patent: 1
Shanghaitech University
Shanghai Shi, China
Patent: 1
Université de Paris 5 René Descartes
France
Patent: 1
Université de Paris
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: